[Optimal therapeutic strategy in type 2 diabetes mellitus].
Scherbaum
W A
WA
Klinik für Endokrinologie, Diabetologie und Rheumatologie, Universitätsklinikum Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Deutschland. scherbaum@uni-duesseldorf.de
Nitschmann
S
S
D000959:Antihypertensive Agents / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D010349:Patient Compliance; D010353:Patient Education as Topic; D011785:Quality Assurance, Health Care / Q000379:methods*
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D007328:Insulin